Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Frequently asked questions
What sector does STRATEC Biomedical AG (SBS) operate in?
STRATEC Biomedical AG belongs to the Healthcare sector and operates in the Medical Devices industry.
What is STRATEC Biomedical AG (SBS) current stock price?
As of the latest data, STRATEC Biomedical AG stock price is €23.30, with a previous close of €23.50. STRATEC Biomedical AG lost -€0.20 in the last trading session, representing a -0.85% loss.
What is STRATEC Biomedical AG (SBS) current market capitalization?
STRATEC Biomedical AG market cap is approximately 283.23 million.
What is STRATEC Biomedical AG (SBS) Earnings Per Share (EPS)?
The trailing EPS is -€0.03, and the forward EPS is €1.74.
What is STRATEC Biomedical AG (SBS) EBITDA?
STRATEC Biomedical AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 8.52 million.
Does STRATEC Biomedical AG (SBS) pay dividends?
Yes. STRATEC Biomedical AG pays annual dividends with an annualized yield of 2.58% and an estimated annual payout of €0.60 per share.
When is the next ex-dividend date for STRATEC Biomedical AG (SBS)?
The next ex-dividend date is scheduled for June 24, 2027.
When is STRATEC Biomedical AG (SBS) next earnings report?
STRATEC Biomedical AG is expected to release its next earnings report on September 30, 2026.
What is STRATEC Biomedical AG (SBS) beta (volatility) score?
STRATEC Biomedical AG has a beta of 0.847, meaning its volatility is roughly in line with the market.
